Chief Executive Officer
United States of America
Mr. Donald Wetherhold, also known as Don, has been the Chief Executive Officer of Aprecia Pharmaceuticals Company since November 2013. Mr. Wetherhold oversees and lead customer retention, national accounts and automation in the long-term care business. He has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Snyder Healthcare Sales and Solvay Pharmaceuticals. Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories' senior vice president and general manager of Hampton Laine. Mr. Wetherhold served as a Senior Vice President of Long-Term Care Group at Omnicare Inc., since October 12, 2012. Mr. Wetherhold served as President of RxPedite. Mr. Wetherhold served as corporate commercialization officer at Aprecia Pharmaceuticals Company. He has also served in senior roles at Cardinal Health, including as President of Sales and Marketing Services, where he conceptualized and sold the business model of providing commercialization and launch solutions to emerging pharmaceutical and biotechnology companies. He served as Trustee of BioOhio, Inc.(also known as OMERIS, Inc).
Business modelling, Planning ,Development, Sales and Marketing